How to Buy solara Shares on Fincept?
You can buy Solara Active Pharma Sciences Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: Solara Active Pharma Sciences Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Solara, including updates on board meetings and corporate actions.
Solara Active Pharma Sciences Limited - https://www.solara.co.in
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-retroviral, antibiotic, anticonvulsant, antidepressant, antifibrinolytics, antifungal, antigout agent, antihelmintic, antihistamine, antihyperlipoproteinemic, antimycotic, antifungal, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antiulcer, antiulcerative, anxiolytic, aprepitant, bile acid analogue, calcimimetic agent, cardiovascular agent, chronic alcoholism, treatment of hyperphosphatemia, hemorrheologic agent, hypercholesterolemia, hypophosphatemic agent, immune-suppressant, loop diuretic, NSAIDs, nucleoside inhibitor, OAB treatment, phenylalanine reducer, phosphate binder, reversal of neuro-muscular blocking agent, skeletal muscle relaxant, and topical anti-infectives. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support. In addition, the company exports its products. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.
Solara Active Pharma Sciences Limited Share Price Today
520.40
OPEN
525.05
HIGH
489.65
LOW
496.50
CLOSE
178 K
VOLUME
2,868 Cr
Market Cap
126709
Average Volume
Healthcare
Sector
NSI
Exchange
Solara Active Pharma Sciences Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: SOLARA Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Solara Active Pharma Sciences Limited |
SOLARA |
INE624Z01016 |
Annual General Meeting |
17 Sep 2024 |
10 |
N/A |
Solara Active Pharma Sciences Limited |
SOLARA |
INE624Z01016 |
Rights 1:3 @ Premium Rs 365/- |
15 May 2024 |
10 |
N/A |
Solara Active Pharma Sciences Limited |
SOLARA |
INE624Z01016 |
Annual General Meeting |
08 Sep 2023 |
10 |
N/A |
Solara Active Pharma Sciences Limited |
SOLARA |
INE624Z01016 |
Annual General Meeting |
12 Aug 2022 |
10 |
N/A |
Solara Active Pharma Sciences Limited |
SOLARA |
INE624Z01016 |
Annual General Meeting/Dividend - Rs 3 Per Share |
18 Aug 2021 |
10 |
N/A |
NSE: SOLARA Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
SOLARA |
27 Dec 2024, 11:34:46 |
Trading Window-XBRL |
N/A |
SOLARA |
27 Dec 2024, 11:22:33 |
Trading Window |
N/A |
SOLARA |
12 Nov 2024, 12:47:32 |
Monitoring Agency Report |
N/A |
SOLARA |
28 Oct 2024, 11:41:43 |
Analysts/Institutional Investor Meet/Con. Call Updates |
N/A |
SOLARA |
23 Oct 2024, 09:42:55 |
Copy of Newspaper Publication |
N/A |
NSE: SOLARA Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Solara Active Pharma Sciences Limited |
SOLARA |
17 Oct 2024, 12:07:00 |
17 Oct 2024, 12:07:00 |
|
Solara Active Pharma Sciences Limited |
SOLARA |
19 Jul 2024, 15:40:00 |
19 Jul 2024, 15:40:00 |
|
Solara Active Pharma Sciences Limited |
SOLARA |
15 May 2024, 16:25:00 |
15 May 2024, 16:25:00 |
|
Solara Active Pharma Sciences Limited |
SOLARA |
11 Jan 2024, 17:00:00 |
11 Jan 2024, 17:30:00 |
|
Solara Active Pharma Sciences Limited |
SOLARA |
19 Oct 2023, 11:45:00 |
19 Oct 2023, 12:15:00 |
NSE: SOLARA Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Independent Director,Chairperson & Non-Executive Director |
06 Jul 1952 |
11 Apr 2018 |
00161542 |
R RAMAKRISHNAN |
Active |
Independent Director |
05 May 1967 |
11 Apr 2018 |
06999168 |
KAUSALYA SANTHANAM |
Active |
Non-Executive Director |
25 Mar 1961 |
04 Aug 2021 |
00084845 |
ARUN KUMAR PILLAI |
Active |
Non-Executive Director |
16 May 1987 |
05 Jul 2023 |
02921819 |
KARTHEEK RAJU CHINTALAPATI |
Active |
Executive Director-CEO-MD |
21 Apr 1979 |
05 Jul 2023 |
10158900 |
POORVANK PUROHIT |
Active |
NSE: SOLARA Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
SOLARA ACTIVE PHARMA SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 21-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2024 . |
SOLARA |
N/A |
INE624Z01016 |
Solara Active Pharma Sciences Limited |
14 Oct 2024, 17:03:40 |
Financial Results |
SOLARA |
N/A |
INE624Z01016 |
Solara Active Pharma Sciences Limited |
15 Jul 2024, 11:16:15 |
Financial Results |
SOLARA |
N/A |
INE624Z01016 |
Solara Active Pharma Sciences Limited |
21 May 2024, 15:44:05 |
SOLARA ACTIVE PHARMA SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 09-May-2024 to consider Fund raising. |
SOLARA |
N/A |
INE624Z01016 |
Solara Active Pharma Sciences Limited |
06 May 2024, 20:42:19 |
Financial Results |
SOLARA |
N/A |
INE624Z01016 |
Solara Active Pharma Sciences Limited |
05 Feb 2024, 16:05:09 |
NSE: SOLARA Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results |
SOLARA |
- |
INE624Z01016 |
Solara Active Pharma Sciences Limited |
14 Oct 2024, 00:00:00 |
To consider and approve the Unaudited Standalone and Consolidated financial results for the quarter and half year ended September 30, 2024 |
Financial Results |
SOLARA |
- |
INE624Z01016 |
Solara Active Pharma Sciences Limited |
15 Jul 2024, 00:00:00 |
To consider and approve the unaudited financial results for the period ended June 30, 2024 |
Financial Results |
SOLARA |
- |
INE624Z01016 |
Solara Active Pharma Sciences Limited |
21 May 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024 |
Fund Raising |
SOLARA |
- |
INE624Z01016 |
Solara Active Pharma Sciences Limited |
06 May 2024, 00:00:00 |
To consider Fund Raising and other business matters |
Financial Results |
SOLARA |
- |
INE624Z01016 |
Solara Active Pharma Sciences Limited |
05 Feb 2024, 00:00:00 |
To consider and approve the unaudited financial results for the period ended December 31, 2023 |
NSE: SOLARA Balance Sheet Data In (Cr)
| date | period_type | Ordinary Shares Number | Share Issued | Net Debt | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Non Current Pension And Other Postretirement Benefit Plans | Non Current Deferred Revenue | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Debt | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Deferred Taxes Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Current Provisions | Payables | Other Payable | Dividends Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Non Current Deferred Taxes Assets | Investmentin Financial Assets | Available For Sale Securities | Investment Properties | Goodwill And Other Intangible Assets | Other Intangible Assets | Goodwill | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Assets Held For Sale Current | Restricted Cash | Prepaid Assets | Inventory | Finished Goods | Work In Process | Raw Materials | Other Receivables | Taxes Receivable | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 48,053,022.00 | 48,053,022.00 | 8,136,600,000.00 | 8,399,500,000.00 | 6,850,500,000.00 | 19,055,900,000.00 | -2,887,700,000.00 | 6,850,500,000.00 | 203,800,000.00 | 10,860,200,000.00 | 11,652,800,000.00 | 10,886,900,000.00 | 26,700,000.00 | 10,860,200,000.00 | 10,458,100,000.00 | 0.00 | 0.00 | 402,100,000.00 | 402,100,000.00 | 12,010,900,000.00 | 1,527,600,000.00 | 449,700,000.00 | 0.00 | 0.00 | 0.00 | 973,200,000.00 | 180,600,000.00 | 792,600,000.00 | 100,500,000.00 | 10,483,300,000.00 | 79,600,000.00 | 100,000.00 | 7,426,300,000.00 | 23,200,000.00 | 7,403,100,000.00 | 19,700,000.00 | 0.00 | 2,812,700,000.00 | 0.00 | 0.00 | 0.00 | 2,812,700,000.00 | 22,897,800,000.00 | 15,304,000,000.00 | 59,300,000.00 | 0.00 | 0.00 | 180,500,000.00 | 180,500,000.00 | 23,300,000.00 | 4,009,700,000.00 | 360,700,000.00 | 3,649,000,000.00 | 10,991,800,000.00 | 0.00 | 10,991,800,000.00 | 2,716,900,000.00 | 8,274,900,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7,595,600,000.00 | 678,700,000.00 | 0.00 | 0.00 | 0.00 | 2,897,100,000.00 | 0.00 | 0.00 | 0.00 | 400,000.00 | 0.00 | 3,838,700,000.00 | 0.00 | 0.00 | 180,700,000.00 | 121,600,000.00 | 59,100,000.00 | 0.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 39,056,736.00 | 39,056,736.00 | 9,909,400,000.00 | 10,115,000,000.00 | 5,262,600,000.00 | 19,332,900,000.00 | -4,421,000,000.00 | 5,262,600,000.00 | 121,200,000.00 | 9,339,100,000.00 | 10,397,400,000.00 | 9,365,800,000.00 | 26,700,000.00 | 9,339,100,000.00 | 16,500,000.00 | -3,175,200,000.00 | 12,160,300,000.00 | 360,000,000.00 | 360,000,000.00 | 14,143,800,000.00 | 1,715,300,000.00 | 435,900,000.00 | 536,700,000.00 | 0.00 | 0.00 | 1,174,400,000.00 | 116,100,000.00 | 1,058,300,000.00 | 100,800,000.00 | 12,428,500,000.00 | 160,300,000.00 | 100,000.00 | 8,940,600,000.00 | 5,100,000.00 | 8,935,500,000.00 | 19,700,000.00 | 19,700,000.00 | 3,265,300,000.00 | 133,600,000.00 | 1,600,000.00 | 0.00 | 3,130,100,000.00 | 23,509,600,000.00 | 15,502,100,000.00 | 52,800,000.00 | 270,000,000.00 | 0.00 | 17,000,000.00 | 17,000,000.00 | 23,900,000.00 | 4,076,500,000.00 | 425,600,000.00 | 3,650,900,000.00 | 11,114,700,000.00 | -5,154,700,000.00 | 16,269,400,000.00 | 2,536,200,000.00 | 8,512,400,000.00 | 9,032,400,000.00 | 3,319,700,000.00 | 1,381,100,000.00 | 0.00 | 8,007,500,000.00 | 634,900,000.00 | 126,800,000.00 | 1,600,000.00 | 227,600,000.00 | 3,597,000,000.00 | 1,285,400,000.00 | 1,428,500,000.00 | 883,100,000.00 | 77,600,000.00 | 407,300,000.00 | 3,485,200,000.00 | -271,900,000.00 | 3,757,100,000.00 | 84,400,000.00 | 75,800,000.00 | 84,400,000.00 | 53,500,000.00 | 30,900,000.00 |
| 2024-03-31T00:00:00 | annual | 39,056,736.00 | 39,056,736.00 | 9,909,400,000.00 | 10,115,000,000.00 | 5,262,600,000.00 | 19,332,900,000.00 | -4,421,000,000.00 | 5,262,600,000.00 | 121,200,000.00 | 9,339,100,000.00 | 10,397,400,000.00 | 9,365,800,000.00 | 26,700,000.00 | 9,339,100,000.00 | 16,500,000.00 | -3,175,200,000.00 | 12,160,300,000.00 | 360,000,000.00 | 360,000,000.00 | 14,143,800,000.00 | 1,715,300,000.00 | 435,900,000.00 | 536,700,000.00 | 0.00 | 0.00 | 1,174,400,000.00 | 116,100,000.00 | 1,058,300,000.00 | 100,800,000.00 | 12,428,500,000.00 | 160,300,000.00 | 100,000.00 | 8,940,600,000.00 | 5,100,000.00 | 8,935,500,000.00 | 19,700,000.00 | 19,700,000.00 | 3,265,300,000.00 | 133,600,000.00 | 1,600,000.00 | 0.00 | 3,130,100,000.00 | 23,509,600,000.00 | 15,502,100,000.00 | 52,800,000.00 | 270,000,000.00 | 0.00 | 17,000,000.00 | 17,000,000.00 | 23,900,000.00 | 4,076,500,000.00 | 425,600,000.00 | 3,650,900,000.00 | 11,114,700,000.00 | -5,154,700,000.00 | 16,269,400,000.00 | 2,536,200,000.00 | 8,512,400,000.00 | 9,032,400,000.00 | 3,319,700,000.00 | 1,381,100,000.00 | 0.00 | 8,007,500,000.00 | 634,900,000.00 | 126,800,000.00 | 1,600,000.00 | 227,600,000.00 | 3,597,000,000.00 | 1,285,400,000.00 | 1,428,500,000.00 | 883,100,000.00 | 77,600,000.00 | 407,300,000.00 | 3,485,200,000.00 | -271,900,000.00 | 3,757,100,000.00 | 84,400,000.00 | 75,800,000.00 | 84,400,000.00 | 53,500,000.00 | 30,900,000.00 |
| 2023-09-30T00:00:00 | quarterly | 39,056,736.00 | 39,056,736.00 | 9,666,400,000.00 | 9,848,500,000.00 | 10,493,000,000.00 | 24,363,700,000.00 | 295,700,000.00 | 10,493,000,000.00 | 119,100,000.00 | 14,634,300,000.00 | 16,438,400,000.00 | 14,662,100,000.00 | 27,800,000.00 | 14,634,300,000.00 | 14,274,300,000.00 | 0.00 | 0.00 | 360,000,000.00 | 360,000,000.00 | 14,091,200,000.00 | 2,437,100,000.00 | 405,800,000.00 | 0.00 | 0.00 | 0.00 | 1,917,900,000.00 | 113,800,000.00 | 1,804,100,000.00 | 109,200,000.00 | 11,654,100,000.00 | 68,200,000.00 | 0.00 | 7,930,600,000.00 | 5,300,000.00 | 7,925,300,000.00 | 0.00 | 20,800,000.00 | 3,480,100,000.00 | 0.00 | 0.00 | 100,000.00 | 3,480,000,000.00 | 28,753,300,000.00 | 16,803,500,000.00 | 68,400,000.00 | 0.00 | 887,800,000.00 | 165,800,000.00 | 165,800,000.00 | 235,900,000.00 | 4,141,300,000.00 | 490,400,000.00 | 3,650,900,000.00 | 11,254,100,000.00 | 0.00 | 11,254,100,000.00 | 2,501,000,000.00 | 8,753,100,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11,949,800,000.00 | 563,300,000.00 | 125,000,000.00 | 0.00 | 0.00 | 5,568,800,000.00 | 0.00 | 0.00 | 0.00 | 224,200,000.00 | 0.00 | 5,258,600,000.00 | 0.00 | 0.00 | 209,900,000.00 | 146,900,000.00 | 63,000,000.00 | 0.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 39,056,736.00 | 39,056,736.00 | 9,924,200,000.00 | 10,128,500,000.00 | 10,807,700,000.00 | 25,013,600,000.00 | 864,100,000.00 | 10,807,700,000.00 | 117,000,000.00 | 15,002,100,000.00 | 17,353,100,000.00 | 15,024,500,000.00 | 22,400,000.00 | 15,002,100,000.00 | 10,500,000.00 | 2,493,100,000.00 | 12,160,300,000.00 | 360,000,000.00 | 360,000,000.00 | 13,968,300,000.00 | 2,957,000,000.00 | 383,600,000.00 | 490,300,000.00 | 0.00 | 0.00 | 2,462,500,000.00 | 111,500,000.00 | 2,351,000,000.00 | 106,700,000.00 | 11,011,300,000.00 | 50,000,000.00 | 100,000.00 | 7,666,000,000.00 | 5,500,000.00 | 7,660,500,000.00 | 20,800,000.00 | 20,800,000.00 | 3,200,100,000.00 | 139,900,000.00 | 1,600,000.00 | 100,000.00 | 3,058,600,000.00 | 28,992,800,000.00 | 17,117,400,000.00 | 100,700,000.00 | 270,400,000.00 | 785,600,000.00 | 17,000,000.00 | 17,000,000.00 | 239,400,000.00 | 4,194,400,000.00 | 543,500,000.00 | 3,650,900,000.00 | 11,602,400,000.00 | -4,454,800,000.00 | 16,057,200,000.00 | 2,396,600,000.00 | 9,205,800,000.00 | 8,948,200,000.00 | 3,331,300,000.00 | 1,381,100,000.00 | 0.00 | 11,875,400,000.00 | 1,800,000.00 | 0.00 | 1,600,000.00 | 134,500,000.00 | 5,580,900,000.00 | 1,583,900,000.00 | 2,749,900,000.00 | 1,247,100,000.00 | 458,500,000.00 | 242,700,000.00 | 5,369,900,000.00 | -162,000,000.00 | 5,531,900,000.00 | 87,300,000.00 | 133,900,000.00 | 87,300,000.00 | 500,000.00 | 86,800,000.00 |
| 2023-03-31T00:00:00 | annual | 39,056,736.00 | 39,056,736.00 | 9,924,200,000.00 | 10,128,500,000.00 | 10,807,700,000.00 | 25,013,600,000.00 | 864,100,000.00 | 10,807,700,000.00 | 117,000,000.00 | 15,002,100,000.00 | 17,353,100,000.00 | 15,024,500,000.00 | 22,400,000.00 | 15,002,100,000.00 | 10,500,000.00 | 2,493,100,000.00 | 12,160,300,000.00 | 360,000,000.00 | 360,000,000.00 | 13,968,300,000.00 | 2,957,000,000.00 | 383,600,000.00 | 490,300,000.00 | 0.00 | 0.00 | 2,462,500,000.00 | 111,500,000.00 | 2,351,000,000.00 | 106,700,000.00 | 11,011,300,000.00 | 50,000,000.00 | 100,000.00 | 7,666,000,000.00 | 5,500,000.00 | 7,660,500,000.00 | 20,800,000.00 | 20,800,000.00 | 3,200,100,000.00 | 139,900,000.00 | 1,600,000.00 | 100,000.00 | 3,058,600,000.00 | 28,992,800,000.00 | 17,117,400,000.00 | 100,700,000.00 | 270,400,000.00 | 785,600,000.00 | 17,000,000.00 | 17,000,000.00 | 239,400,000.00 | 4,194,400,000.00 | 543,500,000.00 | 3,650,900,000.00 | 11,602,400,000.00 | -4,454,800,000.00 | 16,057,200,000.00 | 2,396,600,000.00 | 9,205,800,000.00 | 8,948,200,000.00 | 3,331,300,000.00 | 1,381,100,000.00 | 0.00 | 11,875,400,000.00 | 1,800,000.00 | 0.00 | 1,600,000.00 | 134,500,000.00 | 5,580,900,000.00 | 1,583,900,000.00 | 2,749,900,000.00 | 1,247,100,000.00 | 458,500,000.00 | 242,700,000.00 | 5,369,900,000.00 | -162,000,000.00 | 5,531,900,000.00 | 87,300,000.00 | 133,900,000.00 | 87,300,000.00 | 500,000.00 | 86,800,000.00 |
| 2022-03-31T00:00:00 | annual | 39,056,736.00 | 39,056,736.00 | 9,781,900,000.00 | 10,373,700,000.00 | 10,918,400,000.00 | 25,494,400,000.00 | 1,758,600,000.00 | 10,918,400,000.00 | 128,000,000.00 | 15,248,700,000.00 | 18,079,100,000.00 | 15,271,800,000.00 | 23,100,000.00 | 15,248,700,000.00 | 10,000,000.00 | 2,737,200,000.00 | 12,160,300,000.00 | 360,000,000.00 | 360,000,000.00 | 14,177,800,000.00 | 3,543,600,000.00 | 507,100,000.00 | 370,700,000.00 | 231,300,000.00 | 0.00 | 2,937,400,000.00 | 107,000,000.00 | 2,830,400,000.00 | 94,900,000.00 | 10,634,200,000.00 | 54,000,000.00 | 3,300,000.00 | 7,436,300,000.00 | 21,000,000.00 | 7,415,300,000.00 | 34,400,000.00 | 34,400,000.00 | 2,938,100,000.00 | 176,500,000.00 | 1,700,000.00 | 3,300,000.00 | 2,759,900,000.00 | 29,449,600,000.00 | 17,056,800,000.00 | 315,500,000.00 | 388,400,000.00 | 551,400,000.00 | 4,200,000.00 | 4,200,000.00 | 245,900,000.00 | 4,330,300,000.00 | 679,400,000.00 | 3,650,900,000.00 | 11,525,700,000.00 | -3,621,700,000.00 | 15,147,400,000.00 | 2,538,000,000.00 | 8,987,400,000.00 | 8,064,000,000.00 | 3,164,400,000.00 | 1,381,000,000.00 | 0.00 | 12,392,800,000.00 | 657,000,000.00 | 0.00 | 8,700,000.00 | 132,600,000.00 | 5,755,500,000.00 | 1,907,100,000.00 | 2,496,500,000.00 | 1,351,900,000.00 | 611,100,000.00 | 524,400,000.00 | 4,896,700,000.00 | -105,400,000.00 | 5,002,100,000.00 | 463,800,000.00 | 104,000,000.00 | 463,800,000.00 | 424,700,000.00 | 39,100,000.00 |
| 2021-03-31T00:00:00 | annual | 38,984,582.00 | 38,984,582.00 | 4,092,200,000.00 | 6,207,300,000.00 | 11,434,600,000.00 | 21,954,400,000.00 | 2,688,900,000.00 | 11,434,600,000.00 | 138,200,000.00 | 15,885,300,000.00 | 17,433,600,000.00 | 15,927,700,000.00 | 42,400,000.00 | 15,885,300,000.00 | 37,900,000.00 | 3,388,500,000.00 | 12,117,200,000.00 | 359,300,000.00 | 359,300,000.00 | 10,208,100,000.00 | 2,320,700,000.00 | 536,900,000.00 | 365,600,000.00 | 284,900,000.00 | 0.00 | 1,666,000,000.00 | 117,700,000.00 | 1,548,300,000.00 | 113,600,000.00 | 7,887,400,000.00 | 50,300,000.00 | 1,400,000.00 | 4,541,300,000.00 | 20,500,000.00 | 4,520,800,000.00 | 18,300,000.00 | 18,300,000.00 | 3,135,100,000.00 | 40,700,000.00 | 1,500,000.00 | 1,400,000.00 | 3,092,900,000.00 | 26,135,800,000.00 | 15,559,500,000.00 | 483,800,000.00 | 196,100,000.00 | 256,100,000.00 | 4,200,000.00 | 4,200,000.00 | 252,900,000.00 | 4,450,700,000.00 | 799,800,000.00 | 3,650,900,000.00 | 10,388,600,000.00 | -2,671,000,000.00 | 13,059,600,000.00 | 1,276,400,000.00 | 9,112,200,000.00 | 7,440,300,000.00 | 2,970,800,000.00 | 1,372,100,000.00 | 0.00 | 10,576,300,000.00 | 100,000.00 | 0.00 | 8,500,000.00 | 213,200,000.00 | 2,949,700,000.00 | 484,300,000.00 | 1,480,900,000.00 | 984,500,000.00 | 294,200,000.00 | 295,100,000.00 | 4,838,700,000.00 | -17,200,000.00 | 4,855,900,000.00 | 1,976,900,000.00 | 286,200,000.00 | 1,976,900,000.00 | 1,944,600,000.00 | 32,300,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 427,400,000.00 | 118,300,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 84,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: SOLARA Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Repayment Of Debt | Issuance Of Debt | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Beginning Cash Position | Changes In Cash | Financing Cash Flow | Net Other Financing Charges | Interest Paid Cff | Cash Dividends Paid | Common Stock Dividend Paid | Net Common Stock Issuance | Common Stock Issuance | Net Issuance Payments Of Debt | Net Short Term Debt Issuance | Net Long Term Debt Issuance | Long Term Debt Payments | Long Term Debt Issuance | Investing Cash Flow | Net Other Investing Changes | Interest Received Cfi | Net Investment Purchase And Sale | Purchase Of Investment | Net Business Purchase And Sale | Sale Of Business | Purchase Of Business | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Capital Expenditure Reported | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Other Current Liabilities | Change In Other Current Assets | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Stock Based Compensation | Provisionand Write Offof Assets | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Net Foreign Currency Exchange Gain Loss | Gain Loss On Sale Of PPE | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 678,100,000.00 | -1,184,900,000.00 | 49,000,000.00 | 0.00 | -410,600,000.00 | 84,400,000.00 | 87,300,000.00 | -2,900,000.00 | -1,056,500,000.00 | 0.00 | -1,026,300,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -21,400,000.00 | 1,114,500,000.00 | -1,135,900,000.00 | -1,184,900,000.00 | 49,000,000.00 | -35,100,000.00 | 9,700,000.00 | 31,900,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10,400,000.00 | 10,400,000.00 | 0.00 | -410,600,000.00 | 1,088,700,000.00 | 9,000,000.00 | 1,906,300,000.00 | 128,800,000.00 | -208,000,000.00 | 73,000,000.00 | 130,800,000.00 | 1,781,700,000.00 | 1,624,500,000.00 | 6,000,000.00 | 109,900,000.00 | 1,033,300,000.00 | 132,400,000.00 | 900,900,000.00 | 10,800,000.00 | -3,600,000.00 | -4,884,200,000.00 |
| 2023-03-31T00:00:00 | annual | 449,400,000.00 | -1,306,200,000.00 | 683,000,000.00 | 0.00 | -1,113,100,000.00 | 87,300,000.00 | 463,800,000.00 | -376,500,000.00 | -1,127,600,000.00 | 0.00 | -874,500,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -228,800,000.00 | 394,400,000.00 | -623,200,000.00 | -1,306,200,000.00 | 683,000,000.00 | -811,400,000.00 | 51,500,000.00 | 73,500,000.00 | 0.00 | 0.00 | -12,800,000.00 | 0.00 | -12,800,000.00 | 13,000,000.00 | 13,000,000.00 | -1,113,100,000.00 | -1,113,100,000.00 | 1,562,500,000.00 | 135,400,000.00 | 7,400,000.00 | -250,000,000.00 | 223,200,000.00 | 389,000,000.00 | 173,200,000.00 | -528,000,000.00 | 663,900,000.00 | 500,000.00 | 56,600,000.00 | 1,111,900,000.00 | 156,900,000.00 | 955,000,000.00 | 30,500,000.00 | 4,500,000.00 | -448,200,000.00 |
| 2022-03-31T00:00:00 | annual | -4,506,500,000.00 | -937,600,000.00 | 2,624,000,000.00 | 29,000,000.00 | -2,086,200,000.00 | 463,800,000.00 | 1,976,900,000.00 | -1,513,100,000.00 | 3,335,700,000.00 | 0.00 | -734,000,000.00 | -107,800,000.00 | 0.00 | 29,000,000.00 | 29,000,000.00 | 4,173,100,000.00 | 2,486,700,000.00 | 1,686,400,000.00 | -937,600,000.00 | 2,624,000,000.00 | -2,428,500,000.00 | 55,900,000.00 | 100,500,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,300,000.00 | 1,300,000.00 | -2,086,200,000.00 | -2,086,200,000.00 | -2,420,300,000.00 | -181,000,000.00 | -3,137,900,000.00 | 347,100,000.00 | -294,900,000.00 | -238,800,000.00 | -2,805,800,000.00 | -145,500,000.00 | 550,400,000.00 | -13,100,000.00 | 88,200,000.00 | 1,123,200,000.00 | 152,700,000.00 | 970,500,000.00 | 53,200,000.00 | 7,700,000.00 | -911,000,000.00 |
| 2021-03-31T00:00:00 | annual | -190,200,000.00 | -2,627,900,000.00 | 1,558,200,000.00 | 2,981,600,000.00 | -1,744,800,000.00 | 1,976,900,000.00 | 560,400,000.00 | 1,416,500,000.00 | 924,900,000.00 | 0.00 | -831,900,000.00 | -197,300,000.00 | 0.00 | 2,981,600,000.00 | 2,981,600,000.00 | -1,001,500,000.00 | 68,200,000.00 | -1,069,700,000.00 | -2,627,900,000.00 | 1,558,200,000.00 | -1,063,000,000.00 | 57,000,000.00 | 96,100,000.00 | 500,000,000.00 | 0.00 | -1,000,000.00 | 0.00 | -1,000,000.00 | 29,700,000.00 | 29,700,000.00 | -1,744,800,000.00 | -1,744,800,000.00 | 1,554,600,000.00 | -333,600,000.00 | -2,058,400,000.00 | 88,800,000.00 | -387,800,000.00 | 966,700,000.00 | -152,400,000.00 | -2,573,700,000.00 | 606,400,000.00 | 51,400,000.00 | 0.00 | 1,086,600,000.00 | 141,700,000.00 | 944,900,000.00 | 7,200,000.00 | -20,000,000.00 | 2,215,000,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 297,600,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -27,300,000.00 | 0.00 | -156,200,000.00 | -128,900,000.00 | 297,600,000.00 | 297,600,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -500,000,000.00 | -500,000,000.00 | 0.00 | 900,000.00 | 0.00 | 0.00 | 0.00 | -2,688,700,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: SOLARA Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Minority Interests | Net Income Including Noncontrolling Interests | Net Income Discontinuous Operations | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Write Off | Impairment Of Capital Assets | Restructuring And Mergern Acquisition | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Amortization | Depreciation Income Statement | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | -56.81 | 0.00 | -97.21 | -189.36 | -189.36 | -567.39 | 103.33 | 838.51 | -286.57 | -389.90 | -101.35 | 98.52 | 2.22 | -434.84 | -567.39 | 1,436.47 | 2.76 | 3.91 | 3.91 | 0.00 | 0.00 | -567.39 | -567.39 | 0.00 | -567.39 | -0.43 | -566.96 | 0.00 | -566.96 | 78.54 | -488.42 | 1.24 | -189.36 | 184.50 | 2.33 | 2.53 | 0.00 | -101.35 | 5.05 | 98.52 | 2.22 | -198.08 | 597.96 | 239.97 | 103.33 | 13.24 | 90.09 | 58.51 | 34.18 | 24.33 | 2.76 | 399.88 | 838.51 | 1,238.39 | 1,238.39 |
| 2023-03-31T00:00:00 | annual | 0.12 | 0.00 | 149.36 | 0.39 | 0.39 | -22.18 | 111.19 | 813.22 | 149.75 | 38.56 | -80.86 | 83.38 | 5.78 | -22.45 | -22.18 | 1,346.03 | 1.29 | 3.91 | 3.91 | 0.00 | 0.00 | -22.18 | -22.18 | 0.00 | -22.18 | 0.07 | -22.25 | 0.00 | -22.25 | -22.57 | -44.82 | 5.64 | 0.39 | -0.39 | 0.00 | 0.00 | 0.00 | -80.86 | 3.26 | 83.38 | 5.78 | 33.16 | 532.81 | 200.99 | 111.19 | 15.69 | 95.50 | 55.33 | 31.68 | 23.65 | 1.29 | 565.97 | 813.22 | 1,379.19 | 1,379.19 |
| 2022-03-31T00:00:00 | annual | -1.37 | 0.00 | 92.30 | -3.80 | -3.80 | -58.15 | 112.32 | 681.32 | 88.50 | -23.82 | -62.38 | 67.28 | 7.76 | -55.72 | -58.15 | 1,260.38 | 2.49 | 3.90 | 3.90 | 0.00 | 0.00 | -58.15 | -58.15 | 0.00 | -58.15 | 0.14 | -58.29 | 0.00 | -58.29 | -32.81 | -91.10 | 7.63 | -3.80 | 0.31 | 8.82 | 0.00 | 3.49 | -62.38 | 2.86 | 67.28 | 7.76 | -29.83 | 579.06 | 200.65 | 112.32 | 15.27 | 97.05 | 65.05 | 30.28 | 34.77 | 2.49 | 549.23 | 681.32 | 1,230.55 | 1,230.55 |
| 2021-03-31T00:00:00 | annual | 0.00 | 0.00 | 408.13 | 2.27 | 2.27 | 221.40 | 108.66 | 753.85 | 410.40 | 301.74 | -70.16 | 80.24 | 14.22 | 219.13 | 221.40 | 1,293.01 | 2.97 | 3.72 | 3.48 | 0.00 | 0.00 | 221.40 | 221.40 | 0.00 | 221.40 | -0.05 | 221.35 | 0.00 | 221.35 | 0.15 | 221.50 | 8.46 | 2.27 | -2.27 | 0.00 | 0.00 | 0.00 | -70.16 | 4.14 | 80.24 | 14.22 | 282.72 | 539.16 | 174.51 | 108.66 | 14.17 | 94.49 | 64.80 | 31.88 | 32.92 | 2.97 | 821.88 | 753.85 | 1,575.73 | 1,575.73 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
-136.73
P/E
N/A
P/B
1.9135782
Dividend Yield
N/A
Market Cap
2,868.14 Cr.
Face Value
344.381
Book Value
344.381
ROE
-43.88%
EBITDA Growth
-51.50 Cr.
Debt/Equity
77.152
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of solara?
The market capitalization of Solara Active Pharma Sciences Limited is ₹2,868 Cr as of 05 Feb 2025.
What are the PE and PB ratios of Solara Active Pharma Sciences Limited?
The PE and PB ratios of Solara Active Pharma Sciences Limited are Not Available and 1.9135782 respectively as of 05 Feb 2025.
What is the 52 Week High of Solara Active Pharma Sciences Limited?
The 52-week high of Solara Active Pharma Sciences Limited is ₹882.8 as of 05 Feb 2025.
What is the 52 Week Low of Solara Active Pharma Sciences Limited?
The 52-week low of Solara Active Pharma Sciences Limited is ₹329.05 as of 05 Feb 2025.
What are the earnings per share (EPS) for Solara Active Pharma Sciences Limited?
The Earnings Per Share (EPS) of Solara Active Pharma Sciences Limited is ₹-136.73 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of Solara Active Pharma Sciences Limited?
The Return on Equity (ROE) of Solara Active Pharma Sciences Limited is -43.88% as per the most recent financial year data. Explore more on Fincept.